CEO & Chief Scientific Officer of Amphastar Pharmaceuticals Inc (30-Year Financial, Insider Trades) Jack Y. Zhang (insider trades) sold 40,886 shares of AMPH on 02/09/2021 at an average price of $18.92 a share. The total sale was $773,563.
Amphastar Pharmaceuticals Inc is a specialty pharmaceutical company engaged in developing, manufacturing, marketing and selling generic and proprietary injectable & inhalation products. Its products are used in hospitals or urgent care clinical settings. Amphastar Pharmaceuticals Inc has a market cap of $899.252 million; its shares were traded at around $18.930000 with a P/E ratio of 139.18 and P/S ratio of 2.71. GuruFocus has detected 1 severe warning sign with Amphastar Pharmaceuticals Inc. .
CEO Recent Trades:
- CEO & Chief Scientific Officer, 10% Owner Jack Y. Zhang sold 40,886 shares of AMPH stock on 02/09/2021 at the average price of $18.92. The price of the stock has increased by 0.05% since.
- CEO & Chief Scientific Officer, 10% Owner Jack Y. Zhang sold 41,869 shares of AMPH stock on 02/04/2021 at the average price of $18.69. The price of the stock has increased by 1.28% since.
- CEO & Chief Scientific Officer, 10% Owner Jack Y. Zhang sold 37,931 shares of AMPH stock on 02/02/2021 at the average price of $18.43. The price of the stock has increased by 2.71% since.
CFO Recent Trades:
- CFO, SVP & Treasurer William J Peters sold 6,495 shares of AMPH stock on 01/19/2021 at the average price of $18.67. The price of the stock has increased by 1.39% since.
Directors and Officers Recent Trades:
- Director Floyd F. Petersen sold 639 shares of AMPH stock on 02/01/2021 at the average price of $18.26. The price of the stock has increased by 3.67% since.
For the complete insider trading history of AMPH, click here
.
